base model simcyp simulator version 19 library file (Simcyp)
90
Structured Review
Simcyp
base model simcyp simulator version 19 library file
Base Model Simcyp Simulator Version 19 Library File, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simcyp+simulator+libraries/simulator+version+19/pm33958385-74-0-2
Average 90 stars, based on 1 article reviews
Base Model Simcyp Simulator Version 19 Library File, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simcyp+simulator+libraries/simulator+version+19/pm33958385-74-0-2
Average 90 stars, based on 1 article reviews
base model simcyp simulator version 19 library file - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites Article Snippet: Whole‐body rat and human PBK models were developed using the rat and Article Title: Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs Article Snippet: The study design taken from each clinical case was used for building and verifying the drug PBPK models in healthy volunteers (drug PBPK models in healthy volunteers: budesonide IV [ ], budesonide oral as Entocort ® [ ], midazolam oral [ ]) in the Article Title: Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N-desbutyldronedarone: Application to prospective simulation of complex drug-drug interaction with rivaroxaban. Article Snippet: The in vitro–in vivo correlation module in version 19 of the Article Title: Model informed drug development: HSK21542 PBPK model supporting dose decisions in specific populations. Article Snippet: The Refining:Article Title: Drug-Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model-Based Studies. Article Snippet: Simulations Using a PBPK Model APBPKmodel was previously developed using Simcyp Simulator version 19 (Certara, Princeton, NJ) to investigate the impact of CYP inducers and inhibitors, and CYP2C19 phenotype on mavacamten exposure.23 In December 2021, an updated version of the PBPK software was released, Simcyp Simulator version 21 (Certara, Princeton, NJ), which implemented updates to the CYP2C19 characteristics in the adult population, including the values for hepatic and intestinal CYP2C19 enzyme abundance, changes to the existing UM population, and the addition of IM and RM phenotypes.24 The mavacamten model initially developed in Simcyp nloaded from https://accp1.onlinelibrary.w iley.com /doi/10.1002/jcph.6175 by M anipal A cadem y O f H igher E ducation, W iley O nline L ibrary on [25/12/2024]. .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable Permeability:Article Title: Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis. Article Snippet: .. A linezolid 4-compartment permeability-limited CNS PBPK model was developed using Simcyp Software:Article Title: Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis. Article Snippet: .. A linezolid 4-compartment permeability-limited CNS PBPK model was developed using Simcyp Clinical Proteomics:Article Title: Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis. Article Snippet: .. A linezolid 4-compartment permeability-limited CNS PBPK model was developed using Simcyp Drug discovery:Article Title: Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis. Article Snippet: .. A linezolid 4-compartment permeability-limited CNS PBPK model was developed using Simcyp |